BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26469867)

  • 1. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
    Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
    Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
    Ahlen MT; Heide G; Husebekk A; Skogen B; Kjeldsen-Kragh J; Stuge TB
    Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K; Patriquin CJ; Deniz S; Dzaja N; Smith JW; Wang G; Nazy I; Kelton JG; Arnold DM
    Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
    Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
    J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in fetal and neonatal alloimmune thrombocytopenia.
    Bussel JB; Vander Haar EL; Berkowitz RL
    Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
    Loewenthal R; Rosenberg N; Kalt R; Dardik R; Landau M; Yahalom V; Avishai O; Frenkel O; Gazit E; Steinberg DM; Lipitz S; Salomon O
    Transfusion; 2013 Feb; 53(2):344-52. PubMed ID: 22671039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
    Kjeldsen-Kragh J; Ahlen MT
    Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
    Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
    Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review.
    Tomac G; Gojčeta K; Grizelj R; Coen Herak D; Ostojić SB; Golubić Ćepulić B
    Transfus Med; 2022 Aug; 32(4):269-275. PubMed ID: 35730350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
    Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
    Sachs UJ; Wienzek-Lischka S; Duong Y; Qiu D; Hinrichs W; Cooper N; Santoso S; Bayat B; Bein G
    Br J Haematol; 2020 May; 189(4):751-759. PubMed ID: 31997312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia.
    Bertrand G; Drame M; Martageix C; Kaplan C
    Blood; 2011 Mar; 117(11):3209-13. PubMed ID: 21239703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
    Sainio S; Javela K; Tuimala J; Haimila K
    Br J Haematol; 2017 Jan; 176(1):111-117. PubMed ID: 27748520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
    de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
    Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
    Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
    Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
    Bonstein L; Haddad N
    Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.